Still looks good for Gxy. A %2.55 increase Holding steady @ 44cent over here in North America today.Let's see what it does on the Australian exchange tonight
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%